Change in management at Genmab
This article was originally published in Scrip
Genmab (Denmark) has announced that Dr Claus Møller is to step down from his position as executive vice-president and chief operating officer. He will remain available to the company as Development Advisor for the remainder of 2008. The COO position at Genmab will be discontinued and Dr Møller's responsibilities will be folded into the R&D department which has already been consolidated under the direction of Professor Jan van de Winkel, president of R&D and chief scientific officer.